Conclusion: We found strong evidence that antidepressants differ markedly in their physiological effects, particularly for cardiometabolic parameters. Treatment guidelines should be updated to reflect differences in physiological risk, but choice of antidepressant should be made on an individual basis, considering clinical presentation and preferences of patients, carers, and clinicians.
PubMed 41135546 ↗Dmt
The short answer. There isn't much data on Dmt yet — 25 mentions, 8 with a clear outcome — so treat these numbers as anecdotal. It is well studied — 207 meta-analyses on PubMed.
From 25 mentions in total — the rest didn't say how it went and aren't counted.
What Dmt does, according to users
Of the people who reported each effect, the share who said it got better.
6 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 207 meta-analyses on PubMed ↗ · 121 randomized trials ↗
Conclusion: Nearly a third of the articles reported that no participants reported lasting adverse effects. Our analyses suggest that psychedelics reduce negative mood, and have potential efficacy in other mental disorders, such as substance-use disorders and PTSD.
PubMed 38574699 ↗Conclusion: In this systematic review and meta-analysis, classic psychedelics were generally well tolerated in clinical or research settings according to the existing literature, although SAEs did occur. These results provide estimates of common AE frequencies and indicate that certain catastrophic events reported in recreational or nonclinical contexts have yet to be reported in contemporary trial participants. Careful, ongoing, and improved pharmacovigilance is required to understand the risk and benefit profiles of these substances and to communicate such risks to prospective study participants and the
PubMed 39230883 ↗Conclusion: Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries.
PubMed 36180795 ↗157 human trials on ClinicalTrials.gov test Dmt — 88 completed, 17 recruiting now. See all on ClinicalTrials.gov ↗
- Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects · Healthy Adult · 2026
- Cladribine Tablets as an Exit Therapy Strategy · Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis · 2026
- Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain · Chronic Low-back Pain · 2022
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Dmt is a Schedule I controlled substance in the US (listed as Dimethyltryptamine). DEA controlled-substance list ↗
NIH has funded 5 research projects with Dmt in the title, $1,423,466 in total (1990–2026). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I also frequently use DMT,and I'm convinced that it has had a huge influence on my circadian rhythms.”
“At dosses of about 10mg DMT is the most powerful nootropic I've ever tried.”
“I have heard some case studies of people have improved ability after strokes, etc due to DMT”
Top discussions (5)
- Most life-changing supplement ↗
- My experience with ketamine for increasing emotions ↗
- Has anyone ever cured their depression with a single supplement ↗
- Want to learn more about Neuroscience and Psychedelics? Here's the complete playlist of videos from Andrew Gallimore's Psychedelic Neuroscience Master Course, all for free on YouTube. ↗
- Prolonged Remission of Major Depressive Disorder After Single Nitrous Oxide [laughing gas] Inhalation Treatment | 1h long inhalation dropped depression scale to 0 and lasted for >1 month ↗
Dmt compared
Other options for mood
Sources
- User reports: 25 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- US DEA ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate